Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
Pharmalot
STAT+
The Readout

A biotech ‘Star Search’ & the brains behind EpiPen’s rise

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Aug. 24, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for August 24, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Academia’s postdoc system is teetering, imperiling efforts to diversify…
Academia’s postdoc system is teetering, imperiling efforts to diversify life sciences
How Blue Cross Blue Shield insurers ratcheted up profits…
How Blue Cross Blue Shield insurers ratcheted up profits in 2022
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories